Literature DB >> 22390463

Upstream transcription factor 1 (USF1) polymorphisms associate with Alzheimer's disease-related neuropathological lesions: Tampere Autopsy Study.

Karita Isotalo1, Eloise Helena Kok, Teemu M Luoto, Satu Haikonen, Hannu Haapasalo, Terho Lehtimäki, Pekka J Karhunen.   

Abstract

The apolipoprotein E (APOE) gene associates with Alzheimer's disease (AD) and cholesterol levels. Upstream transcription factor 1 (USF1) regulates lipid metabolism genes, including APOE, and the AD Aβ-precursor protein. We investigated associations between 6 haplotype-tagging USF1 single-nucleotide polymorphisms (and haplotypes) and AD-related neuropathological lesions [senile plaques (SP), neurofibrillary tangles (NFT) ] in an autopsy series comprising 603 cases (ages 0-97, mean 62 years, 215 women) that died out-of-hospital. In age- and APOE-adjusted analyses, the minor G-allele of rs2774276, previously linked to elevated cholesterol, associated with late-stage burnt out SP among women and early non-neuritic SP among men. The G-allele of the previously unreported rs10908821 showed significant risk of having SP, especially neuritic and burnt out SP, among women but not men. USF1 haplotype GCGCAC carriers (risk alleles of rs2774276 and rs10908821) associated with SP risk, especially neuritic and late-stage burnt out SP, among women but not men. Younger CCGCAC carriers (risk allele of rs2774276 and protective of rs10908821) were more likely to have non-neuritic and diffuse SP. Conversely, USF1 CCGCAC haplotype carriers had lower NFT prevalence among 65+ year-olds. These results suggest USF1 has an independent but gender- and age-associated effect on AD-related brain lesion development.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390463     DOI: 10.1111/j.1750-3639.2012.00586.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  8 in total

1.  USF-1 genetic polymorphisms confer a high risk of nonalcoholic fatty liver disease in Chinese population.

Authors:  Ying Wang; Bai-Fang Wang; Jing Tong; Bing Chang; Bing-Yuan Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.

Authors:  John D Merriman; Bradley E Aouizerat; Janine K Cataldo; Laura Dunn; Bruce A Cooper; Claudia West; Steven M Paul; Christina R Baggott; Anand Dhruva; Kord Kober; Dale J Langford; Heather Leutwyler; Christine S Ritchie; Gary Abrams; Marylin Dodd; Charles Elboim; Deborah Hamolsky; Michelle Melisko; Christine Miaskowski
Journal:  Cytokine       Date:  2013-12-04       Impact factor: 3.861

3.  Direct Transcriptional Effects of Apolipoprotein E.

Authors:  Veena Theendakara; Clare A Peters-Libeu; Patricia Spilman; Karen S Poksay; Dale E Bredesen; Rammohan V Rao
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

4.  Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.

Authors:  Mustafa Sertbaş; Kutlu Ulgen; Tunahan Cakır
Journal:  FEBS Open Bio       Date:  2014-06-06       Impact factor: 2.693

5.  Human Brain Reacts to Transcranial Extraocular Light.

Authors:  Lihua Sun; Jari Peräkylä; Anselmi Kovalainen; Keith H Ogawa; Pekka J Karhunen; Kaisa M Hartikainen
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Transcriptomic analysis of neuregulin-1 regulated genes following ischemic stroke by computational identification of promoter binding sites: A role for the ETS-1 transcription factor.

Authors:  Monique C Surles-Zeigler; Yonggang Li; Timothy J Distel; Hakeem Omotayo; Shaokui Ge; Byron D Ford
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  The shape of the human language-ready brain.

Authors:  Cedric Boeckx; Antonio Benítez-Burraco
Journal:  Front Psychol       Date:  2014-04-04

8.  Microarray analysis of verbenalin-treated human amniotic epithelial cells reveals therapeutic potential for Alzheimer's Disease.

Authors:  Farhana Ferdousi; Shinji Kondo; Kazunori Sasaki; Yoshiaki Uchida; Nobuhiro Ohkohchi; Yun-Wen Zheng; Hiroko Isoda
Journal:  Aging (Albany NY)       Date:  2020-03-29       Impact factor: 5.955

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.